These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3520513)

  • 1. [Effect of naloxone on insulin and glucagon secretion in patients with acute renal failure].
    Grzeszczak W; Kokot F; Duława J
    Pol Tyg Lek; 1986 Mar; 41(11):331-4. PubMed ID: 3520513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of L-arginine on glucagon and insulin secretion in patients with acute kidney failure].
    Kuska J; Kokot F; Kulawik E
    Z Gesamte Inn Med; 1984 Feb; 39(3):43-6. PubMed ID: 6369814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of naloxone on insulin and glucagon secretion in patients with chronic renal failure].
    Grzeszczak W; Kokot F; Duława J
    Pol Arch Med Wewn; 1986 May; 75(5):336-43. PubMed ID: 3537985
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of naloxone on endocrine abnormalities in acute renal failure.
    Grzeszczak W; Kokot F; Wiecek A
    Acta Med Pol; 1988; 29(1-2):1-15. PubMed ID: 2855691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endocrine function of the pancreas in patients with acute and chronic renal failure].
    Wnuk R; Kokot F; Mleczko Z
    Pol Arch Med Wewn; 1983 Sep; 70(3):111-23. PubMed ID: 6361704
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of naloxone administration on endocrine abnormalities in chronic renal failure.
    Grzeszczak W; Kokot F; Duława J
    Am J Nephrol; 1987; 7(2):93-100. PubMed ID: 3037907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The metabolism of glucose in renal insufficiency].
    Tchobroutsky G; de l'Hortet GC; Gillis B; Rosselin G; Assan R; Freychet P; Derot M
    J Urol Nephrol (Paris); 1968; 74(4):293-309. PubMed ID: 5675111
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of naloxone-induced opiate receptors blockade on insulin secretion in obesity.
    Vettor R; Martini C; Manno M; Cestaro S; Federspil G; Sicolo N
    Horm Metab Res; 1985 Jul; 17(7):374-5. PubMed ID: 2993144
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
    Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.
    Larsson H; Berglund G; Ahrén B
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1778-82. PubMed ID: 7775622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon and insulin secretion and their biological activities in hypothermic rats.
    Helman A; Gilbert M; Pfister-Lemaire N; Réach G; Assan R
    Endocrinology; 1984 Nov; 115(5):1722-8. PubMed ID: 6436006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the lipid metabolism indicators, glucose tolerance and insulin and glucagon secretion during conservative treatment of thyrotoxicosis. Summary of the thesis].
    Lopatyński J
    Endokrynol Pol; 1981; 32(3):285-93. PubMed ID: 7030727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of carbohydrate metabolic disorders and of the secretion of insulin, glucagon and somatotropin in patients with chronic glomerulonephritis and chronic kidney failure].
    Trusov VV; Kazakova IA; Nasachev AA
    Ter Arkh; 1986; 58(8):13-8. PubMed ID: 3532406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and glucagon secretion in the ketotic (idiopathic glucagon unresponsive) hypoglycemia of childhood.
    Falorni A; Massi-Benedetti F; Sposito M; Barboni G; Lato M
    J Endocrinol Invest; 1979; 2(1):51-7. PubMed ID: 489917
    [No Abstract]   [Full Text] [Related]  

  • 15. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
    Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of gastrointestinal hormones on insulin and glucagon secretion.
    Creutzfeldt W; Feurle G; Ketterer H
    N Engl J Med; 1970 May; 282(20):1139-41. PubMed ID: 4909197
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of naloxone on lutropin, follitropin, prolactin and testosterone secretion in patients with acute renal failure].
    Grzeszczak W; Kokot F; Duława J
    Pol Tyg Lek; 1985 Jun; 40(22):620-5. PubMed ID: 3931064
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade.
    Vance JE; Buchanan KD; O'Hara D; Williams RH; Porte D
    J Clin Endocrinol Metab; 1969 Jul; 29(7):911-6. PubMed ID: 5793451
    [No Abstract]   [Full Text] [Related]  

  • 19. Normalization of insulin and glucagon secretion in ketosis-resistant diabetes mellitus with prolonged diet therapy.
    Savage PJ; Bennion LJ; Bennett PH
    J Clin Endocrinol Metab; 1979 Dec; 49(6):830-3. PubMed ID: 117019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of calcium antagonist on glucose-induced insulin and glucagon secretion in rats with insulin-secreting tumors induced by streptozotocin and nicotinamide.
    Baba S; Yoshino G; Kazumi T; Fujii S; Yoshida Y; Taniguchi H; Morita S
    Kobe J Med Sci; 1979 Jun; 25(2):93-104. PubMed ID: 224248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.